FIELD: medicine. SUBSTANCE: invention proposes novel agent for treatment and prophylaxis of pancreatitis. Invention proposes the known insulin sensibilizing agents, especially thiazolidinedione compounds, for example, troglytazon, oxazolidinedione compounds or oxadiazolidinedione compounds. EFFECT: broadened arsenal of agents of indicated prescription. 34 cl, 12 tbl
Title | Year | Author | Number |
---|---|---|---|
USE OF THIAZOLIDINE DERIVATIVES FOR PROPHYLAXIS AND TREATMENT OF PATIENTS WITH OSTEOPOROSIS | 1996 |
|
RU2146521C1 |
METHOD AND COMPOSITION FOR TREATING AND PREVENTING HYPERURICEMIA | 1998 |
|
RU2190425C2 |
INTERMEDIATE COMPOUND FOR SYNTHESIS OF HETEROCYCLIC COMPOUNDS SHOWING ANTIDIABETIC ACTIVITY | 1995 |
|
RU2151145C1 |
SUBSTITUTED CONDENSED HETEROCYCLIC COMPOUND, METHOD OF PHARMACOLOGICAL EFFECT, METHOD OF INHIBITION OF 5-LIPOXYGENASE ACTIVITY, INHIBITION OF LIPID PEROXIDES PRODUCTION OR BLOOD SUGAR LEVEL DECREASE | 1998 |
|
RU2196141C2 |
THIAZOLIDINE COMPOUNDS, METHOD OF PREPARATION THEREOF, METHOD OF REDUCING SUGAR CONTENT IN BLOOD OF MAMMALS | 1992 |
|
RU2095354C1 |
DERIVATIVES OF BENZIMIDAZOLE, PHARMACEUTICAL COMPOSITION BASED ON SAID AND THERAPEUTIC USE OF BENZIMIDAZOLE DERIVATIVES | 1996 |
|
RU2125048C1 |
APPLICATION OF THIAZOLIDINEDIONES FOR PREVENTION OR ONSET POSTPONEMENT OF INSULIN-INDEPENDENT DIABETES MELLITUS (NIDDM) | 1994 |
|
RU2195282C2 |
ANTICANCER PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2419430C2 |
PHARMACEUTICAL COMPOSITION USED FOR TREATMENT AND PROPHYLAXIS OF OBESITY-ASSOCIATED HYPERTENSION | 1991 |
|
RU2093149C1 |
DERIVATIVES OF THIAZOLIDINE-2,4-DIONE AND METHOD FOR ITS PRODUCTION | 1992 |
|
RU2103265C1 |
Authors
Dates
2001-05-27—Published
1997-03-17—Filed